Geode Capital Management LLC Has $681.49 Million Stake in Mettler-Toledo International, Inc. $MTD

Geode Capital Management LLC lifted its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 0.6% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 581,847 shares of the medical instruments supplier’s stock after acquiring an additional 3,383 shares during the quarter. Geode Capital Management LLC owned about 2.82% of Mettler-Toledo International worth $681,489,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Russell Investments Group Ltd. lifted its stake in shares of Mettler-Toledo International by 29.0% in the first quarter. Russell Investments Group Ltd. now owns 116,502 shares of the medical instruments supplier’s stock worth $137,548,000 after buying an additional 26,171 shares during the last quarter. Legato Capital Management LLC raised its holdings in Mettler-Toledo International by 107.7% in the 1st quarter. Legato Capital Management LLC now owns 2,050 shares of the medical instruments supplier’s stock worth $2,421,000 after acquiring an additional 1,063 shares during the period. Tokio Marine Asset Management Co. Ltd. lifted its position in Mettler-Toledo International by 46.7% during the 1st quarter. Tokio Marine Asset Management Co. Ltd. now owns 7,829 shares of the medical instruments supplier’s stock worth $9,245,000 after acquiring an additional 2,493 shares during the last quarter. Sound Income Strategies LLC boosted its holdings in Mettler-Toledo International by 477.8% during the second quarter. Sound Income Strategies LLC now owns 52 shares of the medical instruments supplier’s stock valued at $61,000 after acquiring an additional 43 shares during the period. Finally, LPL Financial LLC grew its position in shares of Mettler-Toledo International by 16.3% in the first quarter. LPL Financial LLC now owns 5,404 shares of the medical instruments supplier’s stock valued at $6,382,000 after purchasing an additional 758 shares during the last quarter. 95.07% of the stock is currently owned by institutional investors and hedge funds.

Mettler-Toledo International Price Performance

Shares of MTD stock opened at $1,404.27 on Friday. Mettler-Toledo International, Inc. has a one year low of $946.69 and a one year high of $1,471.06. The stock has a fifty day moving average price of $1,334.60 and a 200 day moving average price of $1,248.36. The stock has a market cap of $28.69 billion, a P/E ratio of 35.56, a price-to-earnings-growth ratio of 4.19 and a beta of 1.41.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings data on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $10.62 by $0.53. The company had revenue of $1.03 billion during the quarter, compared to analysts’ expectations of $997.36 million. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The business’s revenue was up 7.9% on a year-over-year basis. During the same quarter in the prior year, the company posted $10.21 EPS. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS. FY 2025 guidance at 42.050-42.250 EPS. Equities research analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 EPS for the current year.

Insider Buying and Selling at Mettler-Toledo International

In related news, CEO Patrick Kaltenbach sold 2,000 shares of the business’s stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $1,462.50, for a total value of $2,925,000.00. Following the sale, the chief executive officer owned 3,670 shares of the company’s stock, valued at $5,367,375. The trade was a 35.27% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Elisha W. Finney sold 474 shares of the company’s stock in a transaction on Monday, November 10th. The shares were sold at an average price of $1,433.57, for a total value of $679,512.18. Following the completion of the sale, the director owned 311 shares in the company, valued at $445,840.27. This trade represents a 60.38% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 11,549 shares of company stock worth $16,736,223 in the last three months. 1.94% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several analysts recently weighed in on MTD shares. JPMorgan Chase & Co. increased their target price on Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the company a “neutral” rating in a research note on Thursday, October 9th. Evercore ISI upped their price target on Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the stock an “outperform” rating in a report on Tuesday, October 7th. Robert W. Baird raised their price objective on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a “neutral” rating in a research note on Monday, August 4th. Bank of America upped their target price on shares of Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a “neutral” rating in a research note on Monday, September 22nd. Finally, Stifel Nicolaus increased their price target on shares of Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the company a “buy” rating in a report on Monday, November 10th. Five research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $1,406.50.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.